Origin cumulation under the ASEAN–Japan Free Trade Agreement allows raw materials and components from all ASEAN member states and Japan to be recognized as originating materials in the manufacture of pharmaceutical products.
Source: https://www.asean.org/storage/2020/11/ASEAN-Japan-FTA.pdf
Matching tools and partners
You might also be interested in these terms
Free · No password · Never a paywall. Weekly top news and facts from logistics.
Content reviewed and editorially cleared.
Share your knowledge, ask follow-up questions, or add practical insights to this page. Every contribution is moderated before publication.